Stock A084650 LABGENOMICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News LabGenomics Co., Ltd.

Equities

A084650

KR7084650001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2,740 KRW 0.00% Intraday chart for LabGenomics Co., Ltd. +2.24% -28.92%
2023 LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd. CI
2023 LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd.
CI
LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd.
CI
Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others
CI
N Citron, Inc. announced that it has received KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.
CI
N Citron, Inc. announced that it expects to receive KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.
CI
LabGenomics Co., Ltd. announced that it has received KRW 22.71198072 billion in funding
CI
LabGenomics Co., Ltd. announced that it expects to receive KRW 34.09367874 billion in funding
CI
LabGenomics Co., Ltd. announced that it expects to receive KRW 82.71198072 billion in funding from Luha Private Equity and another investor
CI
LabGenomics Co., Ltd.'s Equity Buyback announced on May 28, 2021, has expired.
CI
Tranche Update on LabGenomics Co., Ltd.'s Equity Buyback Plan announced on May 28, 2021.
CI
LabGenomics Co., Ltd. announces an Equity Buyback for 214,132 shares.
CI
LabGenomics Co., Ltd. authorizes a Buyback Plan.
CI
LabGenomics : Maryland audit faults procurement of 500K virus tests
AQ
Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors
CI
LabGenomics Co., Ltd.(KOSDAQ:A084650) added to S&P Global BMI Index
CI
LabGenomics Co., Ltd. agreed to acquire 9.09% stake in Calth Corporation for KRW 2 billion.
CI
Contextual Genomics Partners with Lab Genomics
CI
LabGenomics Co., Ltd's Equity Buyback announced on July 30, 2019, has expired.
CI
LabGenomics Co., Ltd. announces an Equity Buyback for 101,419 shares.
CI
LabGenomics Co., Ltd. authorizes a Buyback Plan.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A084650 Stock
  4. News LabGenomics Co., Ltd.